Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Leamon

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|April 29, 2017
Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapyChristopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
The Journal of Organic Chemistry|April 29, 2010
Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugatesIontcho R Vlahov, Hari Krishna R Santhapuram, Fei You, et al.
Molecular Pharmaceutics|July 28, 2009
In vivo structural activity and optimization studies of folate-tubulysin conjugatesJoseph A Reddy, Ryan Dorton, Alicia Dawson, et al.
Cancer Research|July 10, 2007
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugateJoseph A Reddy, Elaine Westrick, Hari K R Santhapuram, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acidIontcho R Vlahov, Gregory D Vite, Paul J Kleindl, et al.
Bioconjugate Chemistry|February 26, 2014
Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationshipChristopher P Leamon, Iontcho R Vlahov, Joseph A Reddy, et al.
The AAPS Journal|September 4, 2009
Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancerYingjuan Lu, Patrick J Klein, Elaine Westrick, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2013
Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitisYingjuan Lu, Kristin N Wollak, Vicky A Cross, et al.
Cells|August 27, 2021
A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in RatsGabriela E Garcia, Yingjuan J Lu, Luan D Truong, et al.
Molecular Pharmaceutics|July 30, 2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic KidneysHaiyan Chu, Jonathan M Shillingford, Joseph A Reddy, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|April 29, 2017
Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapyChristopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
The Journal of Organic Chemistry|April 29, 2010
Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugatesIontcho R Vlahov, Hari Krishna R Santhapuram, Fei You, et al.
Molecular Pharmaceutics|July 28, 2009
In vivo structural activity and optimization studies of folate-tubulysin conjugatesJoseph A Reddy, Ryan Dorton, Alicia Dawson, et al.
Cancer Research|July 10, 2007
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugateJoseph A Reddy, Elaine Westrick, Hari K R Santhapuram, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acidIontcho R Vlahov, Gregory D Vite, Paul J Kleindl, et al.
Bioconjugate Chemistry|February 26, 2014
Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationshipChristopher P Leamon, Iontcho R Vlahov, Joseph A Reddy, et al.
The AAPS Journal|September 4, 2009
Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancerYingjuan Lu, Patrick J Klein, Elaine Westrick, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2013
Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitisYingjuan Lu, Kristin N Wollak, Vicky A Cross, et al.
Cells|August 27, 2021
A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in RatsGabriela E Garcia, Yingjuan J Lu, Luan D Truong, et al.
Molecular Pharmaceutics|July 30, 2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic KidneysHaiyan Chu, Jonathan M Shillingford, Joseph A Reddy, et al.
Pageof 8